Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

American Family Physician September 15, 2005 Mounsey, Matthew & Slawson	Herpes Zoster and Postherpetic Neuralgia: Prevention and Management The recognizable appearance and the dermatomal distribution of herpes zoster (shingles) lesions usually enable a clinical diagnosis to be made easily. Herpes zoster and postherpetic neuralgia occur mainly in older patients.
American Family Physician November 1, 2002 Shaikh & Ta	Evaluation and Management of Herpes Zoster Ophthalmicus Timely diagnosis and management of herpes zoster ophthalmicus, with referral to an ophthalmologist when ophthalmic involvement is present, are critical in limiting visual morbidity.
American Family Physician December 1, 2002 Sanford R. Kimmel	Vaccine Adverse Events: Separating Myth from Reality Vaccines have turned many childhood diseases into distant memories in industrialized countries. However, questions have been raised about the safety of some vaccines because of rare but serious adverse effects that have been attributed to them.
American Family Physician July 15, 2003 Sur et al.	Vaccinations in Pregnancy Routine vaccines that generally are safe to administer during pregnancy include diphtheria, tetanus, influenza, and hepatitis B. Other vaccines, such as meningococcal and rabies, may be considered.
American Family Physician June 15, 2006 Brundage & Fitzpatrick	Hepatitis A The introduction of hepatitis A vaccines in 1995 led to a drop in the number of reported cases of hepatitis A and a shift to a higher percentage of cases occurring in older age groups. The hepatitis A virus survives for extended periods in the environment.
Health May 2008 Jessica Snyder Sachs	Seven Vaccines You Need Right Now Why those childhood shots (whooping cough, mumps, and more) may have worn off - and what to do.
The Motley Fool September 24, 2009 Brian Orelli	Drugmakers' HIV Treatments Live On Companies that make HIV drugs could lose billions of dollars in revenue if an effective vaccine is developed. All drug-company investors need to keep an eye on up-and-coming drugs from competitors that could take market share.
American Family Physician September 1, 2003 Maurer et al.	Smallpox Vaccine: Contraindications, Administration, and Adverse Reactions Public health departments and the U.S. military have begun the process of vaccinating soldiers and civilian first-responders. Smallpox vaccination carries some serious risks.
American Family Physician August 15, 2000 Harry D. Mckinnon	Evaluating the Febrile Patient with a Rash The differential diagnosis for febrile patients with a rash is extensive...
Nurse Practitioner May 2012 Hammersla & Kapustin	Peripheral Neuropathy: Evidence-based treatment of a complex disorder Peripheral neuropathy is a common and often progressive condition frequently seen in primary care. The chronic pain associated with PN, or neuropathic pain, can significantly diminish patients' quality of life and be challenging to treat.
American Family Physician September 15, 2005	Shingles: Easing the Pain A patient overview of the disease, its causes and treatment options.
American Family Physician January 15, 2001 Charles P. Mouton	Common Infections in Older Adults Despite advances in antibiotic therapy, infectious diseases continue to be a major cause of mortality in older adults. The diagnostic and therapeutic nuances of managing infections in older adults create special challenges for physicians...
The Motley Fool September 25, 2007 Brian Orelli	Cold HIV Vaccine Gets Frozen Phase 2 clinical trials of Merck's HIV vaccine were frozen, leaving the door open for other drugmakers that have vaccines of their own in early trials. Investors, take note.
American Family Physician May 15, 2001 Richard Kent Zimmerman	Pneumococcal Conjugate Vaccine for Young Children Pneumococcal conjugate vaccine, approved in 2000 for use in the United States, was designed to cover the seven serotypes that account for about 80 percent of invasive infections in children younger than six years...
American Family Physician July 1, 2000 Monica Preboth	Practice Guidelines ACIP Issues Recommendations for the 2000-2001 Influenza Season
American Family Physician May 1, 2003 O'Brien & Halverson	Recognition and Management of Bioterrorism Infections Familiarity with the infectious agents of highest priority can expedite diagnosis and initial management, and lead to a successful public health response to such an attack.
Chemistry World July 29, 2015 Maria Burke	Malaria vaccine approval first marred by efficacy question mark After decades of research, a malaria vaccine has finally been given the green light by a regulatory agency. But with limited efficacy and questions over the vaccine's cost, its future remains unclear.
American Family Physician July 1, 2004 Lo Re & Gluckman	Travel Immunizations The approach to vaccine recommendations should be based on a thorough assessment of the risks for travel-related diseases, the time available before trip departure, and current knowledge of the epidemiology of vaccine-preventable diseases.
Managed Care October 2000 Kevin A. Wilson	Public Policy Largely Ignores Adult Immunization Needs Although four fifths of the nation's children are fully immunized, tens of thousands of adults die each year from diseases preventable by vaccination...
BusinessWeek October 22, 2007 Catherine Arnst	Roll Up Your Sleeve, Gramps A graying population may create a huge market for vaccines that buttress aging immune systems.
Popular Mechanics February 11, 2010 Adam Hadhazy	The Truth About 9 Anti-Vaccine Studies Led by celebrities such as Jenny McCarthy, the anti-vaccine movement continues to vehemently oppose mainstream science's overwhelming consensus that vaccines do not cause developmental disorders.
AskMen.com December 22, 2002 Mike Davison	A Man's Guide To The Flu Shot The flu vaccine is 70 to 90% effective in preventing the flu in healthy adult males. It is still possible to contract the flu after immunization, but typically those who have been vaccinated develop a much milder case of the flu.
Chemistry World August 5, 2015 Emma Stoye	Vaccine raises hopes of an end to Ebola A Phase III trial for a candidate Ebola vaccine has shown extremely encouraging results in Guinea, demonstrating complete protection for all those who were vaccinated.
Health October 2007 Sarah Clachar	Read this BEFORE you get a flu shot The flu vaccine may not be as good -- or as safe -- as you think.
Wired January 2003 Richard Martin	Testing the First AIDS Vaccine Medical establishment, government, and Genentech be damned -- Don Francis has never stopped believing. Now he's about to finish testing the first human AIDS vaccine.
Chemistry World October 9, 2013 Phillip Broadwith	GSK to apply for malaria vaccine approval Preliminary results from the first ever Phase III clinical trial of a malaria vaccine show that it can reduce malaria infections in vaccinated children over 18 months.
American Family Physician April 15, 2005 Kirkham, Harris & Grzybowski	Evidence-Based Prenatal Care: Part II. Third-Trimester Care and Prevention of Infectious Diseases Recommendations for care, disease screening, labor induction and vaccinations for patients during late pregnancy.
The Motley Fool August 21, 2009 Brian Orelli	Forget Swine Flu: The Big Money Is Here Vaccines are pharma's, and possibly investors', best friend.
American Family Physician May 15, 2001	Pneumococcal Conjugate Vaccine: What a Parent Needs to Know Why should my child get this vaccine?... What exactly is the pneumococcal vaccine?... Are there some children who should not get pneumococcal conjugate vaccine or who should wait until they are older?...
AskMen.com	1 Million Swine Flu Cases? Swine flu has infected as many as 1 million Americans, U.S. health officials said Thursday, adding that 6 percent or more of some urban populations are infected.
BusinessWeek November 29, 2004 Kerry Capell	"A Vaccine Every Woman Should Take" Two drug companies are closing in on shots against HPV, the leading cause of cervical cancer. Despite the obvious benefits, the vaccines may not be an easy sell: There are social and moral hurdles to overcome.
AskMen.com Jacob Franek	Swine Flu Update With the fall flu season rapidly approaching, a swine flu update is warranted.
Scientific American February 2006	To Banish a Cancer Two vaccines that are nearing approval by the Food and Drug Administration in the U.S. have demonstrated in clinical trials that they can prevent infection from the two types of the human papillomavirus (HPV) that account for up to 70 percent of cervical cancers.
Pharmaceutical Executive July 10, 2014 Fitzpatrick & Mohan	Vaccines: Fire in the Cold Chain It's only recently that vaccine producers experienced the commercial returns commensurate with vaccines: long record of positive public health performance.
Managed Care September 2006 Thomas Morrow	Remarkable Work Went Into Designing the New HPV Vaccine The recently approved human papillomavirus vaccine is a prime example of how science is beating back the advance of old diseases.
The Motley Fool December 30, 2008 Brian Orelli	A Shot in the Arm for Novartis' Pipeline The company picks up the rights to a vaccine that fights a virus.
The Motley Fool July 25, 2007 Brian Orelli	Hopeful Flu Production Technology From Baxter While the clinical trial demonstrating strong immunogenicity for the new vaccine is certainly good news, the continued development of the production technology is probably the more important item for investors.
The Motley Fool January 31, 2011 Brian Orelli	Drug Approved! Now Who's Going to Launch It? Depomed gets pain-free news from the FDA.
Pharmaceutical Executive May 1, 2006 Joanna Breitstein	Cervical Cancer: Endagered Species Preventive care is more efficient than treating disease after the fact. Now this paradigm takes hold in cancer with new HPV vaccines. Now that the science is in order, Merck and GSK face several important challenges in conditioning the market.
Popular Mechanics September 2006 Ben Harder	Seeking Immunity Pathogens like West Nile virus show no respect for borders. But a new class of vaccines may soon keep them in check.
The Motley Fool February 23, 2010 Brian Orelli	The End of a Swine Flu Era A Food and Drug Administration advisory panel recommended yesterday that next year's seasonal flu vaccine contain the vaccine for the H1N1 virus, aka the swine flu.
Pharmaceutical Executive December 1, 2010 Walter Armstrong	Vaccines: Progress in Preventing Bad Bugs Long on the sidelines of pharma R&D, vaccine development is moving to center stage as most of the big pharmas diversify, spreading their risk among the full gamut of revenue sources.
The Motley Fool July 22, 2005 Karl Thiel	Cancer Drug: A Shot at Success Cancer vaccine pioneer Dendreon delivered news yesterday that its investors have been anxiously awaiting: final three-year survival data from a phase 3 study of Provenge, the company's flagship prostate cancer vaccine.
Chemistry World September 26, 2007 Victoria Gill	HIV Vaccines 'Will Not Work' Just days after US drug firm Merck revealed its leading HIV vaccine candidate had flopped in clinical trials, a leading immunologist has predicted that many other vaccines in the pipeline will also fail because their design is similarly flawed.
BusinessWeek February 4, 2010 Weintraub et al.	Swine Flu: The Pandemic That Wasn't Swine flu is waning, but the lessons of H1N1 could come in handy during a more serious epidemic.
Chemistry World August 4, 2008 Pete Mitchell	Vaccine failures shake up HIV research Prospects for an HIV vaccine have receded with the July decision by the US government National Institutes of Health (NIH) to cancel trials of its main vaccine candidate.
Managed Care February 2005 Jack McCain	Managed Care (and Everyone Else) Unprepared for the Next Killer Flu Could avian flu give rise to a pandemic that might rival the fearsome Spanish flu? Is the nation ready? Health plans may be called upon to administer vaccinations and identify high-risk patients, but what about he millions of Americans who lack health insurance?
Chemistry World February 7, 2008 Hepeng Jia	Profile: Vaccine Trailblazer Yin Weidong is one of the leading lights of China's fast growing biotech industry and Sinovac the first Chinese biotech firm listed on the US stock exchange.
American Family Physician January 15, 2004	Influenza Vaccine What is influenza?... Who is at higher risk?... What is the flu vaccine?... Is the vaccine safe?... etc.
Pharmaceutical Executive August 1, 2011 Ted Prusik	Cure for the Common Cold Chain Break An increasing number of pharmaceutical products prescribed in the US -- including insulin, vaccines, biologics, chemotherapeutic agents, blood products, and many antibiotics -- are temperature-sensitive.